Cargando…

A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD

Allogeneic hematopoietic cell transplantation (allo-HSCT) is a reconstruction process of hematopoietic and immune functions that can be curative in patients with hematologic malignancies, but it carries risks of graft-versus-host disease (GVHD), thrombotic microangiopathy (TMA), Epstein–Barr virus (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiahua, Zhang, Xueyan, Chen, Yiru, Zheng, Qingqing, Zhao, Mingyi, Jiang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098338/ https://www.ncbi.nlm.nih.gov/pubmed/35571252 http://dx.doi.org/10.1155/2022/2124627

Ejemplares similares

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
por: Pan, Quanren, et al.
Publicado: (2021)

Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier
por: Bu, Xiaoyin, et al.
Publicado: (2023)

Impact of oral microbiota on pathophysiology of GVHD
por: Yamamoto, Akira, et al.
Publicado: (2023)

Gut-grabbing T cells trigger GVHD
por: Van Epps, Heather L.
Publicado: (2005)

Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD
por: Bruce, Danny W., et al.
Publicado: (2021)

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
por: Zhao, Ye, et al.
Publicado: (2021)

Implication of Gut Microbiota in Cardiovascular Diseases
por: Zhou, Wenyi, et al.
Publicado: (2020)

Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD
por: Jarosch, Sebastian, et al.
Publicado: (2023)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
por: Kostareva, Irina, et al.
Publicado: (2022)

Effects of changes on gut microbiota in children with acute Kawasaki disease
por: Shen, Jie, et al.
Publicado: (2020)

Roles of the intestinal microbiota and microbial metabolites in acute GVHD
por: Lin, Dandan, et al.
Publicado: (2021)

Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD
por: Köhler, Natalie, et al.
Publicado: (2019)

Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
por: Ouyang, Jing, et al.
Publicado: (2020)

Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity
por: Bu, Xiaoyin, et al.
Publicado: (2023)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
por: Ara, Takahide, et al.
Publicado: (2021)

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
por: Zhu, Manlian, et al.
Publicado: (2022)

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
por: Wang, Zhilei, et al.
Publicado: (2022)

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
por: Ramalingam, Sendhilnathan, et al.
Publicado: (2021)

Influence of Flax Seeds on the Gut Microbiota of Elderly Patients with Constipation
por: Ma, Jianxia, et al.
Publicado: (2022)

Single-cell immune profiling reveals a developmentally distinct CD4(+) GM-CSF(+) T-cell lineage that induces GI tract GVHD
por: Piper, Clint, et al.
Publicado: (2022)

A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

New insights about immune populations in gastrointestinal GvHD
por: Hayase, Eiko, et al.
Publicado: (2023)

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
por: Chen, Xiaofeng, et al.
Publicado: (2023)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Microbiota and epigenetics: promising therapeutic approaches?
por: El-Sayed, Amr, et al.
Publicado: (2021)

Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment
por: Bartolini, Ilenia, et al.
Publicado: (2021)

The science behind TCM and Gut microbiota interaction—their combinatorial approach holds promising therapeutic applications
por: Xia, Wenrui, et al.
Publicado: (2022)

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
por: Wang, Jingyue, et al.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases
por: Vieira, Angélica Thomaz, et al.
Publicado: (2016)

Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives
por: Sun, Lijuan, et al.
Publicado: (2018)

NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota
por: Niño-Narvión, Julia, et al.
Publicado: (2023)

The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
por: Jain, Arpit, et al.
Publicado: (2023)

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome
por: Li, Xiaoqing, et al.
Publicado: (2020)

A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD
por: Sofi, M. Hanief, et al.
Publicado: (2021)

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
por: Lu, Yuting, et al.
Publicado: (2022)

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
por: Mhandire, Kudakwashe, et al.
Publicado: (2021)

Effects of immune system cells in GvHD and corresponding therapeutic strategies
por: Tavaf, Maryam Jadid, et al.
Publicado: (2023)

Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition
por: Zhao, Yanna, et al.
Publicado: (2022)

Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies
por: Lei, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_olh12a8kl77v936i59kodgsgk4